High Tower Advisors, LLC Cara Therapeutics, Inc. Transaction History

High Tower Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$12.45 - $23.47 $636,892 - $1.2 Million	-51,156 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$17.57 - $23.95 $42,238 - $57,575	2,404 Added 4.93%	51,156 $1.22 Million
Q2 2018 Aug 14, 2018	BUY	$11.6 - $19.27 $366,270 - $608,450	31,575 Added 183.82%	48,752 $932,000
Q1 2018 May 15, 2018	BUY	$11.77 - $16.08 $202,173 - $276,206	17,177 New	17,177 $212,000
Q3 2017 Nov 14, 2017	SELL	$12.6 - $16.34 $129,893 - $168,449	-10,309 Closed	0 $0

Q2 2017 Aug 14, 2017	BUY	N/A	10,309	10,309 $157,000

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.